top of page


Below you will find links and information regarding our past and present clinical trials.

Leukocyte Adhesion Deficiency Type II  (LAD Type II)

Study of ORL-101 (L-fucose) in Patients With Leukocyte Adhesion Deficiency Type II

Status: Recruiting

Leukocyte Adhesion Disorder- Type II, commonly known as LAD-II, is a carbohydrate- deficient glycoprotein syndrome. It is an extremely rare disease resulting from mutations in the SLC35C1 gene.

Orpha Labs, AG is currently conducting a trial to treat this disorder. If you or a family member has been diagnosed and would like to learn more about this study, please email

bottom of page